Voyager Therapeutics (VYGR) Non-Current Assets (2014 - 2026)

Voyager Therapeutics has disclosed Non-Current Assets across 13 years of filings, most recently posting $72.3 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $72.3 million, down 33.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $284.9 million (down 14.07% YoY), and the FY2025 annual result was $49.6 million, down 57.34% from the prior year.
• Non-Current Assets came in at $72.3 million for Q1 2026 at Voyager Therapeutics, up from $49.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $116.2 million in Q4 2024 to a low of $31.6 million in Q4 2023.
• The 5-year median for Non-Current Assets is $52.6 million (2024), against an average of $57.0 million.
• Across the five-year window, Non-Current Assets jumped 267.89% in 2024 and plunged 57.34% in 2025, its largest moves.
• Voyager Therapeutics' Non-Current Assets stood at $34.9 million in 2022, then declined by 9.35% to $31.6 million in 2023, then surged by 267.89% to $116.2 million in 2024, then slumped by 57.34% to $49.6 million in 2025, then surged by 45.87% to $72.3 million in 2026.
• The last three Non-Current Assets figures came in at $72.3 million (Q1 2026), $49.6 million (Q4 2025), and $68.7 million (Q3 2025), per Business Quant data.